155 related articles for article (PubMed ID: 37378300)
1. Chemo-radiotherapy with
Cruz-Nova P; Gibbens-Bandala B; Ancira-Cortez A; Ramírez-Nava G; Santos-Cuevas C; Luna-Gutiérrez M; Ocampo-García B
Front Med (Lausanne); 2023; 10():1191315. PubMed ID: 37378300
[TBL] [Abstract][Full Text] [Related]
2. Development of
Trujillo-Nolasco M; Cruz-Nova P; Ferro-Flores G; Gibbens-Bandala B; Morales-Avila E; Aranda-Lara L; Vargas M; Ocampo-García B
J Biomed Nanotechnol; 2021 Feb; 17(2):263-278. PubMed ID: 33785097
[TBL] [Abstract][Full Text] [Related]
3.
Gibbens-Bandala B; Morales-Avila E; Ferro-Flores G; Santos-Cuevas C; Meléndez-Alafort L; Trujillo-Nolasco M; Ocampo-García B
Mater Sci Eng C Mater Biol Appl; 2019 Dec; 105():110043. PubMed ID: 31546458
[TBL] [Abstract][Full Text] [Related]
4. Preparation and in vitro evaluation of radiolabeled HA-PLGA nanoparticles as novel MTX delivery system for local treatment of rheumatoid arthritis.
Trujillo-Nolasco RM; Morales-Avila E; Ocampo-García BE; Ferro-Flores G; Gibbens-Bandala BV; Escudero-Castellanos A; Isaac-Olive K
Mater Sci Eng C Mater Biol Appl; 2019 Oct; 103():109766. PubMed ID: 31349410
[TBL] [Abstract][Full Text] [Related]
5. Development, Characterization, and Investigation of In Vivo Targeted Delivery Efficacy of Luteolin-Loaded, Eudragit S100-Coated mPEG-PLGA Nanoparticles.
Liu X; Zhang M; Tian Y; Liu R; Wang Y; Guo F; Gong Y; Yan M
AAPS PharmSciTech; 2022 Mar; 23(4):100. PubMed ID: 35348949
[TBL] [Abstract][Full Text] [Related]
6. Co-delivery of sorafenib and metapristone encapsulated by CXCR4-targeted PLGA-PEG nanoparticles overcomes hepatocellular carcinoma resistance to sorafenib.
Zheng N; Liu W; Li B; Nie H; Liu J; Cheng Y; Wang J; Dong H; Jia L
J Exp Clin Cancer Res; 2019 May; 38(1):232. PubMed ID: 31151472
[TBL] [Abstract][Full Text] [Related]
7. Anti-EGFR-mAb and 5-Fluorouracil Conjugated Polymeric Nanoparticles for Colorectal Cancer.
Bhattacharya S
Recent Pat Anticancer Drug Discov; 2021; 16(1):84-100. PubMed ID: 33349222
[TBL] [Abstract][Full Text] [Related]
8. Poly (lactic-co-glycolic acid)-encapsulated iodine-131 nanoparticles fabricated with rhTSH induce apoptosis and immobilization of thyroid cancer cells.
Fan Y; Xiong Y; Wang X; Chen J; Fang D; Huang J; Yuan G
Front Oncol; 2023; 13():1030105. PubMed ID: 36776316
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of cytotoxic and tumor targeting capability of (177)Lu-DOTATATE-nanoparticles: a trailblazing strategy in peptide receptor radionuclide therapy.
Arora G; Dubey P; Shukla J; Ghosh S; Bandopadhyaya G
Ann Nucl Med; 2016 Jun; 30(5):334-45. PubMed ID: 26897009
[TBL] [Abstract][Full Text] [Related]
10.
Mohajershojai T; Jha P; Boström A; Frejd FY; Yazaki PJ; Nestor M
Front Oncol; 2022; 12():849338. PubMed ID: 35433442
[TBL] [Abstract][Full Text] [Related]
11. PLGA nanoparticles for peptide receptor radionuclide therapy of neuroendocrine tumors: a novel approach towards reduction of renal radiation dose.
Arora G; Shukla J; Ghosh S; Maulik SK; Malhotra A; Bandopadhyaya G
PLoS One; 2012; 7(3):e34019. PubMed ID: 22442740
[TBL] [Abstract][Full Text] [Related]
12. Enhanced antitumor efficacy in colon cancer using EGF functionalized PLGA nanoparticles loaded with 5-Fluorouracil and perfluorocarbon.
Wu P; Zhou Q; Zhu H; Zhuang Y; Bao J
BMC Cancer; 2020 Apr; 20(1):354. PubMed ID: 32345258
[TBL] [Abstract][Full Text] [Related]
13. Dual receptor specific nanoparticles targeting EGFR and PD-L1 for enhanced delivery of docetaxel in cancer therapy.
Emami F; Duwa R; Banstola A; Woo SM; Kwon TK; Yook S
Biomed Pharmacother; 2023 Sep; 165():115023. PubMed ID: 37329708
[TBL] [Abstract][Full Text] [Related]
14. Development of α-tocopherol surface-modified targeted delivery of 5-fluorouracil-loaded poly-D, L-lactic-co-glycolic acid nanoparticles against oral squamous cell carcinoma.
Srivastava S; Gupta S; Mohammad S; Ahmad I
J Cancer Res Ther; 2019; 15(3):480-490. PubMed ID: 31169208
[TBL] [Abstract][Full Text] [Related]
15. CXCR4-targeted lipid-coated PLGA nanoparticles deliver sorafenib and overcome acquired drug resistance in liver cancer.
Gao DY; Lin TsT; Sung YC; Liu YC; Chiang WH; Chang CC; Liu JY; Chen Y
Biomaterials; 2015 Oct; 67():194-203. PubMed ID: 26218745
[TBL] [Abstract][Full Text] [Related]
16. Anti-cancer effect of fenbendazole-incorporated PLGA nanoparticles in ovarian cancer.
Chang CS; Ryu JY; Choi JK; Cho YJ; Choi JJ; Hwang JR; Choi JY; Noh JJ; Lee CM; Won JE; Han HD; Lee JW
J Gynecol Oncol; 2023 Sep; 34(5):e58. PubMed ID: 37170725
[TBL] [Abstract][Full Text] [Related]
17. Unveiling the therapeutic potential of cabozantinib-loaded poly D,L-lactic-co-glycolic acid and polysarcosine nanoparticles in inducing apoptosis and cytotoxicity in human HepG2 hepatocellular carcinoma cell lines and
Bhattacharya S; Parihar VK; Prajapati BG
Front Oncol; 2023; 13():1125857. PubMed ID: 36874145
[TBL] [Abstract][Full Text] [Related]
18. A light-controllable specific drug delivery nanoplatform for targeted bimodal imaging-guided photothermal/chemo synergistic cancer therapy.
Guo Y; Wang XY; Chen YL; Liu FQ; Tan MX; Ao M; Yu JH; Ran HT; Wang ZX
Acta Biomater; 2018 Oct; 80():308-326. PubMed ID: 30240955
[TBL] [Abstract][Full Text] [Related]
19. Translocator protein ligand-PLGA conjugated nanoparticles for 5-fluorouracil delivery to glioma cancer cells.
Laquintana V; Denora N; Lopalco A; Lopedota A; Cutrignelli A; Lasorsa FM; Agostino G; Franco M
Mol Pharm; 2014 Mar; 11(3):859-71. PubMed ID: 24410438
[TBL] [Abstract][Full Text] [Related]
20. Synthesis, physicochemical characterization, and in vitro evaluation of biodegradable PLGA nanoparticles entrapped to folic acid for targeted delivery of kaempferitrin.
Govindarasu M; Abirami P; Alharthi SS; Thiruvengadam M; Rajakumar G; Vaiyapuri M
Biotechnol Appl Biochem; 2022 Dec; 69(6):2387-2398. PubMed ID: 35020231
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
